ARTURO MD MOLINA
CIK 1398940 · Chief Medical Officer · last filed 2026-03-27
ARTURO MD MOLINA is a Chief Medical Officer who has filed 32 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for PTGX, was dated Mar 27, 2026. Across all open-market trades the lifetime net is −$8.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.97M
4
32
-$8.79M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTGX | Chief Medical Officer | 99,115 | $109.78 | $10.88M | -$8.84M | 15 | 2026-03-27 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Director | 0 | $20.01 | $0 | $0 | 3 | 2022-10-14 |
| STRO | Chief Medical Officer | 37,736 | $28.80 | $1.09M | $50.0K | 11 | 2022-03-07 |
| Cougar Biotechnology, Inc. (CGRB) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2009-07-07 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-27 | PTGX | Mixed | — | -$1.45M | EDGAR |
| 2026-01-27 | PTGX | Mixed | −13,151 | -$1.82M | EDGAR |
| 2026-01-21 | PTGX | Sell (S) | −9,514 | -$784.7K | EDGAR |
| 2026-01-06 | PTGX | Grant (A) | +25,600 | $0 | EDGAR |
| 2025-11-19 | PTGX | Sell (S) | −2,712 | -$229.9K | EDGAR |
| 2025-06-11 | PTGX | Mixed | — | -$964.6K | EDGAR |
| 2025-03-14 | PTGX | Mixed | — | -$953.9K | EDGAR |
| 2025-01-17 | PTGX | Sell (S) | −3,640 | $0 | EDGAR |
| 2025-01-06 | PTGX | Grant (A) | +41,088 | $0 | EDGAR |
| 2024-11-27 | PTGX | Mixed | — | -$1.16M | EDGAR |